| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.46e-07 | 37 | 32 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.86e-07 | 38 | 32 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.62e-06 | 739 | 32 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.80e-05 | 37 | 32 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.89e-05 | 127 | 32 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 5.64e-05 | 262 | 32 | 5 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone binding | 5.95e-05 | 265 | 32 | 5 | GO:0042393 | |
| GeneOntologyMolecularFunction | zinc ion binding | 6.16e-05 | 891 | 32 | 8 | GO:0008270 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.41e-04 | 167 | 32 | 4 | GO:0031490 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 1.67e-04 | 67 | 32 | 3 | GO:0031492 | |
| GeneOntologyMolecularFunction | structural molecule activity | 4.35e-04 | 891 | 32 | 7 | GO:0005198 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 4.49e-04 | 1189 | 32 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 4.91e-04 | 645 | 32 | 6 | GO:0140640 | |
| GeneOntologyMolecularFunction | nucleosome binding | 5.13e-04 | 98 | 32 | 3 | GO:0031491 | |
| GeneOntologyMolecularFunction | helicase activity | 2.04e-03 | 158 | 32 | 3 | GO:0004386 | |
| GeneOntologyMolecularFunction | peptidase activity | 3.59e-03 | 654 | 32 | 5 | GO:0008233 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 4.73e-03 | 430 | 32 | 4 | GO:0004175 | |
| GeneOntologyBiologicalProcess | viral process | 4.71e-05 | 464 | 30 | 6 | GO:0016032 | |
| GeneOntologyBiologicalProcess | DNA topological change | 9.14e-05 | 10 | 30 | 2 | GO:0006265 | |
| GeneOntologyBiologicalProcess | DNA recombination | 1.74e-04 | 368 | 30 | 5 | GO:0006310 | |
| GeneOntologyBiologicalProcess | chromatin organization | 2.41e-04 | 896 | 30 | 7 | GO:0006325 | |
| GeneOntologyCellularComponent | chromatin | 4.68e-05 | 1480 | 32 | 10 | GO:0000785 | |
| HumanPheno | Cryptorchidism | 1.34e-05 | 780 | 8 | 7 | HP:0000028 | |
| HumanPheno | Generalized joint hypermobility | 4.26e-05 | 48 | 8 | 3 | HP:0002761 | |
| HumanPheno | Vertebral segmentation defect | 6.25e-05 | 162 | 8 | 4 | HP:0003422 | |
| HumanPheno | Joint laxity | 6.42e-05 | 55 | 8 | 3 | HP:0001388 | |
| HumanPheno | Abnormality of refraction | 1.55e-04 | 709 | 8 | 6 | HP:0000539 | |
| HumanPheno | Vertebral fusion | 1.56e-04 | 74 | 8 | 3 | HP:0002948 | |
| HumanPheno | Abnormal testis morphology | 1.67e-04 | 1129 | 8 | 7 | HP:0000035 | |
| HumanPheno | Non-obstructive azoospermia | 1.70e-04 | 1132 | 8 | 7 | HP:0011961 | |
| HumanPheno | Astigmatism | 1.96e-04 | 217 | 8 | 4 | HP:0000483 | |
| HumanPheno | Azoospermia | 1.97e-04 | 1157 | 8 | 7 | HP:0000027 | |
| HumanPheno | Abnormal spermatogenesis | 2.39e-04 | 1190 | 8 | 7 | HP:0008669 | |
| HumanPheno | Abnormal palate morphology | 2.55e-04 | 1202 | 8 | 7 | HP:0000174 | |
| HumanPheno | Abnormal male internal genitalia morphology | 3.20e-04 | 1243 | 8 | 7 | HP:0000022 | |
| HumanPheno | Functional abnormality of male internal genitalia | 3.68e-04 | 1269 | 8 | 7 | HP:0000025 | |
| HumanPheno | Abnormal male reproductive system physiology | 4.66e-04 | 1314 | 8 | 7 | HP:0012874 | |
| HumanPheno | Abnormal male external genitalia morphology | 5.03e-04 | 1329 | 8 | 7 | HP:0000032 | |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | 5.39e-04 | 1343 | 8 | 7 | HP:0009115 | |
| HumanPheno | Abnormal external genitalia | 6.22e-04 | 1372 | 8 | 7 | HP:0000811 | |
| HumanPheno | Abnormal finger morphology | 6.63e-04 | 1385 | 8 | 7 | HP:0001167 | |
| HumanPheno | Webbed neck | 7.21e-04 | 124 | 8 | 3 | HP:0000465 | |
| HumanPheno | Clinodactyly | 7.48e-04 | 574 | 8 | 5 | HP:0030084 | |
| HumanPheno | Abnormality of the male genitalia | 8.49e-04 | 1437 | 8 | 7 | HP:0010461 | |
| Domain | Chromo_domain | 5.34e-06 | 24 | 27 | 3 | IPR023780 | |
| Domain | BAT2_N | 6.03e-06 | 3 | 27 | 2 | IPR009738 | |
| Domain | BAT2_N | 6.03e-06 | 3 | 27 | 2 | PF07001 | |
| Domain | PRRC2 | 6.03e-06 | 3 | 27 | 2 | IPR033184 | |
| Domain | Chromo | 6.85e-06 | 26 | 27 | 3 | PF00385 | |
| Domain | CHROMO_2 | 8.62e-06 | 28 | 27 | 3 | PS50013 | |
| Domain | CHROMO_1 | 8.62e-06 | 28 | 27 | 3 | PS00598 | |
| Domain | SNF2_N | 1.30e-05 | 32 | 27 | 3 | PF00176 | |
| Domain | SNF2_N | 1.30e-05 | 32 | 27 | 3 | IPR000330 | |
| Domain | Chromodomain-like | 1.30e-05 | 32 | 27 | 3 | IPR016197 | |
| Domain | CHROMO | 1.43e-05 | 33 | 27 | 3 | SM00298 | |
| Domain | Chromo/shadow_dom | 1.43e-05 | 33 | 27 | 3 | IPR000953 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.71e-05 | 35 | 27 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 2.20e-05 | 38 | 27 | 3 | PS00690 | |
| Domain | BRK | 3.01e-05 | 6 | 27 | 2 | SM00592 | |
| Domain | BRK_domain | 3.01e-05 | 6 | 27 | 2 | IPR006576 | |
| Domain | BRK | 3.01e-05 | 6 | 27 | 2 | PF07533 | |
| Domain | Helicase_C | 4.84e-04 | 107 | 27 | 3 | PF00271 | |
| Domain | HELICc | 4.84e-04 | 107 | 27 | 3 | SM00490 | |
| Domain | Helicase_C | 4.97e-04 | 108 | 27 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 5.11e-04 | 109 | 27 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.11e-04 | 109 | 27 | 3 | PS51192 | |
| Domain | DEXDc | 5.11e-04 | 109 | 27 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.25e-04 | 110 | 27 | 3 | IPR014001 | |
| Domain | SANT | 2.36e-03 | 50 | 27 | 2 | SM00717 | |
| Domain | SANT/Myb | 2.55e-03 | 52 | 27 | 2 | IPR001005 | |
| Domain | HMG_box_dom | 3.96e-03 | 65 | 27 | 2 | IPR009071 | |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 4.73e-05 | 10 | 15 | 2 | M7239 | |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 5.78e-05 | 11 | 15 | 2 | MM1349 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 8.19e-05 | 13 | 15 | 2 | M1018 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.36e-03 | 52 | 15 | 2 | M2341 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ANKRD11 PRAM1 HMGB2 HMGN2 CHD7 CHD4 SCML2 RRBP1 SLC4A1AP PRRC2A PHIP PRRC2C TOP2B | 9.85e-13 | 954 | 32 | 13 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ANKRD11 PRR12 HMGN2 CHD6 CHD7 CHD4 SCML2 ZNF276 RRBP1 CTR9 TOP2B | 1.14e-08 | 1294 | 32 | 11 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.27e-08 | 774 | 32 | 9 | 15302935 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 2.46e-08 | 94 | 32 | 5 | 21542922 | |
| Pubmed | 3.38e-08 | 1103 | 32 | 10 | 34189442 | ||
| Pubmed | 1.03e-07 | 251 | 32 | 6 | 31076518 | ||
| Pubmed | 5.72e-07 | 18 | 32 | 3 | 18664271 | ||
| Pubmed | CHD chromatin remodelling enzymes and the DNA damage response. | 8.20e-07 | 2 | 32 | 2 | 23954449 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.11e-06 | 608 | 32 | 7 | 36089195 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.56e-06 | 934 | 32 | 8 | 33916271 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 2.00e-06 | 1318 | 32 | 9 | 30463901 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 28533432 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 3.07e-06 | 109 | 32 | 4 | 33554859 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 3.52e-06 | 724 | 32 | 7 | 36232890 | |
| Pubmed | 3.92e-06 | 469 | 32 | 6 | 27634302 | ||
| Pubmed | 4.17e-06 | 1442 | 32 | 9 | 35575683 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 4.22e-06 | 475 | 32 | 6 | 31040226 | |
| Pubmed | 4.45e-06 | 268 | 32 | 5 | 33640491 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.92e-06 | 4 | 32 | 2 | 10469592 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 11356838 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 8.19e-06 | 5 | 32 | 2 | 12629516 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 8.19e-06 | 5 | 32 | 2 | 11401426 | |
| Pubmed | 8.52e-06 | 43 | 32 | 3 | 26030138 | ||
| Pubmed | 1.21e-05 | 154 | 32 | 4 | 36490346 | ||
| Pubmed | 1.25e-05 | 332 | 32 | 5 | 37433992 | ||
| Pubmed | 1.30e-05 | 157 | 32 | 4 | 30186101 | ||
| Pubmed | 2.09e-05 | 177 | 32 | 4 | 26206133 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 2.23e-05 | 180 | 32 | 4 | 30110629 | |
| Pubmed | 2.56e-05 | 653 | 32 | 6 | 22586326 | ||
| Pubmed | 2.60e-05 | 655 | 32 | 6 | 35819319 | ||
| Pubmed | 2.81e-05 | 191 | 32 | 4 | 31177093 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.85e-05 | 394 | 32 | 5 | 27248496 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.50e-05 | 202 | 32 | 4 | 33005030 | |
| Pubmed | 3.50e-05 | 202 | 32 | 4 | 24639526 | ||
| Pubmed | 3.77e-05 | 418 | 32 | 5 | 34709266 | ||
| Pubmed | 4.80e-05 | 731 | 32 | 6 | 29298432 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.81e-05 | 440 | 32 | 5 | 34244565 | |
| Pubmed | 4.82e-05 | 1497 | 32 | 8 | 31527615 | ||
| Pubmed | 4.88e-05 | 733 | 32 | 6 | 34672954 | ||
| Pubmed | 5.14e-05 | 223 | 32 | 4 | 20020773 | ||
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 14557543 | ||
| Pubmed | 6.36e-05 | 13 | 32 | 2 | 27174565 | ||
| Pubmed | 7.41e-05 | 14 | 32 | 2 | 28317875 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 8.29e-05 | 807 | 32 | 6 | 22681889 | |
| Pubmed | 8.38e-05 | 253 | 32 | 4 | 29911972 | ||
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 10932191 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 1.08e-04 | 847 | 32 | 6 | 35235311 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.09e-04 | 271 | 32 | 4 | 32433965 | |
| Pubmed | 1.11e-04 | 17 | 32 | 2 | 37072811 | ||
| Pubmed | 1.11e-04 | 101 | 32 | 3 | 26949739 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.19e-04 | 533 | 32 | 5 | 30554943 | |
| Pubmed | 1.39e-04 | 551 | 32 | 5 | 34728620 | ||
| Pubmed | 1.87e-04 | 22 | 32 | 2 | 38507412 | ||
| Pubmed | 1.99e-04 | 123 | 32 | 3 | 35583604 | ||
| Pubmed | 1.99e-04 | 317 | 32 | 4 | 30997501 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 2.29e-04 | 329 | 32 | 4 | 34316702 | |
| Pubmed | 2.39e-04 | 131 | 32 | 3 | 34551306 | ||
| Pubmed | 2.43e-04 | 334 | 32 | 4 | 30425250 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 2.50e-04 | 1415 | 32 | 7 | 28515276 | |
| Pubmed | Elongin A regulates transcription in vivo through enhanced RNA polymerase processivity. | 2.63e-04 | 26 | 32 | 2 | 33298525 | |
| Pubmed | 2.86e-04 | 1014 | 32 | 6 | 32416067 | ||
| Pubmed | 2.98e-04 | 650 | 32 | 5 | 38777146 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.26e-04 | 361 | 32 | 4 | 26167880 | |
| Pubmed | 3.28e-04 | 29 | 32 | 2 | 21834987 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 3.31e-04 | 665 | 32 | 5 | 30457570 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 3.35e-04 | 147 | 32 | 3 | 28977470 | |
| Pubmed | Analysis of the Tropism of SARS-CoV-2 Based on the Host Interactome of the Spike Protein. | 3.75e-04 | 31 | 32 | 2 | 37939376 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 3.77e-04 | 375 | 32 | 4 | 32788342 | |
| Pubmed | 3.77e-04 | 153 | 32 | 3 | 10718198 | ||
| Pubmed | TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains. | 4.25e-04 | 33 | 32 | 2 | 33567268 | |
| Pubmed | 4.63e-04 | 396 | 32 | 4 | 26687479 | ||
| Pubmed | 4.76e-04 | 399 | 32 | 4 | 35987950 | ||
| Pubmed | A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation. | 5.07e-04 | 36 | 32 | 2 | 29089422 | |
| Pubmed | 5.67e-04 | 1153 | 32 | 6 | 29845934 | ||
| Pubmed | 6.03e-04 | 425 | 32 | 4 | 24999758 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 6.03e-04 | 759 | 32 | 5 | 35915203 | |
| Pubmed | 6.35e-04 | 183 | 32 | 3 | 36129980 | ||
| Pubmed | Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. | 6.58e-04 | 41 | 32 | 2 | 15561718 | |
| Pubmed | 7.23e-04 | 43 | 32 | 2 | 26487511 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 8.23e-04 | 462 | 32 | 4 | 31138677 | |
| Interaction | SMC5 interactions | ANKRD11 PRAM1 HMGB2 HMGN2 CHD7 CHD4 SCML2 RRBP1 SLC4A1AP PRRC2A PHIP PRRC2C TOP2B | 1.91e-10 | 1000 | 28 | 13 | int:SMC5 |
| Interaction | H3C1 interactions | HMGB2 HMGN2 CHD7 CHD4 RRBP1 CAMSAP1 CTR9 PHIP PRRC2C TOP2B H1-3 | 1.43e-08 | 901 | 28 | 11 | int:H3C1 |
| Interaction | H2BC21 interactions | 1.69e-08 | 696 | 28 | 10 | int:H2BC21 | |
| Interaction | H2BC8 interactions | 5.08e-08 | 576 | 28 | 9 | int:H2BC8 | |
| Interaction | H2BC12 interactions | 2.21e-07 | 322 | 28 | 7 | int:H2BC12 | |
| Interaction | CENPA interactions | 6.40e-07 | 377 | 28 | 7 | int:CENPA | |
| Interaction | H2BC4 interactions | 1.26e-06 | 259 | 28 | 6 | int:H2BC4 | |
| Interaction | HMGA1 interactions | 1.30e-06 | 419 | 28 | 7 | int:HMGA1 | |
| Interaction | CBX3 interactions | 1.88e-06 | 646 | 28 | 8 | int:CBX3 | |
| Interaction | SSRP1 interactions | 2.91e-06 | 685 | 28 | 8 | int:SSRP1 | |
| Interaction | TWIST1 interactions | 3.38e-06 | 170 | 28 | 5 | int:TWIST1 | |
| Interaction | POLR1G interactions | 3.61e-06 | 489 | 28 | 7 | int:POLR1G | |
| Interaction | CEBPA interactions | 3.67e-06 | 1245 | 28 | 10 | int:CEBPA | |
| Interaction | HDAC4 interactions | 5.36e-06 | 744 | 28 | 8 | int:HDAC4 | |
| Interaction | H3-3A interactions | 5.63e-06 | 749 | 28 | 8 | int:H3-3A | |
| Interaction | COIL interactions | 7.99e-06 | 552 | 28 | 7 | int:COIL | |
| Interaction | H3C15 interactions | 8.83e-06 | 207 | 28 | 5 | int:H3C15 | |
| Interaction | POU5F1 interactions | 1.15e-05 | 584 | 28 | 7 | int:POU5F1 | |
| Interaction | H2BC3 interactions | 1.67e-05 | 406 | 28 | 6 | int:H2BC3 | |
| Interaction | H3-5 interactions | 1.79e-05 | 114 | 28 | 4 | int:H3-5 | |
| Interaction | SRP9 interactions | 2.22e-05 | 427 | 28 | 6 | int:SRP9 | |
| Interaction | ZNF330 interactions | 2.83e-05 | 446 | 28 | 6 | int:ZNF330 | |
| Interaction | H2BC9 interactions | 2.83e-05 | 446 | 28 | 6 | int:H2BC9 | |
| Interaction | H3-4 interactions | 2.90e-05 | 448 | 28 | 6 | int:H3-4 | |
| Interaction | RPL31 interactions | 3.08e-05 | 680 | 28 | 7 | int:RPL31 | |
| Interaction | RAD18 interactions | 3.24e-05 | 457 | 28 | 6 | int:RAD18 | |
| Interaction | SMARCA4 interactions | 3.45e-05 | 462 | 28 | 6 | int:SMARCA4 | |
| Interaction | NAA40 interactions | 3.90e-05 | 978 | 28 | 8 | int:NAA40 | |
| Interaction | RPS16 interactions | 4.59e-05 | 724 | 28 | 7 | int:RPS16 | |
| Interaction | PARP1 interactions | 4.66e-05 | 1316 | 28 | 9 | int:PARP1 | |
| Interaction | BRD3 interactions | 5.01e-05 | 494 | 28 | 6 | int:BRD3 | |
| Interaction | H3C3 interactions | 5.07e-05 | 495 | 28 | 6 | int:H3C3 | |
| Interaction | SOX5 interactions | 7.09e-05 | 162 | 28 | 4 | int:SOX5 | |
| Interaction | NR2C2 interactions | 7.69e-05 | 1403 | 28 | 9 | int:NR2C2 | |
| Interaction | CEBPB interactions | 9.56e-05 | 1443 | 28 | 9 | int:CEBPB | |
| Interaction | SRP68 interactions | 1.62e-04 | 381 | 28 | 5 | int:SRP68 | |
| Interaction | MEX3A interactions | 1.68e-04 | 384 | 28 | 5 | int:MEX3A | |
| Interaction | NECAP1 interactions | 1.70e-04 | 78 | 28 | 3 | int:NECAP1 | |
| Interaction | LRRC31 interactions | 1.76e-04 | 205 | 28 | 4 | int:LRRC31 | |
| Interaction | FBL interactions | 2.06e-04 | 639 | 28 | 6 | int:FBL | |
| Interaction | LINC00240 interactions | 2.21e-04 | 16 | 28 | 2 | int:LINC00240 | |
| Interaction | NUCKS1 interactions | 2.30e-04 | 220 | 28 | 4 | int:NUCKS1 | |
| Interaction | KDM1A interactions | 2.36e-04 | 941 | 28 | 7 | int:KDM1A | |
| Interaction | H1-4 interactions | 2.37e-04 | 656 | 28 | 6 | int:H1-4 | |
| Interaction | APEX1 interactions | 2.44e-04 | 1271 | 28 | 8 | int:APEX1 | |
| Interaction | H1-2 interactions | 2.58e-04 | 666 | 28 | 6 | int:H1-2 | |
| Interaction | DNAJC8 interactions | 2.73e-04 | 230 | 28 | 4 | int:DNAJC8 | |
| Interaction | CTR9 interactions | 2.87e-04 | 233 | 28 | 4 | int:CTR9 | |
| Interaction | RNF113A interactions | 3.16e-04 | 692 | 28 | 6 | int:RNF113A | |
| Interaction | SUPT16H interactions | 3.21e-04 | 442 | 28 | 5 | int:SUPT16H | |
| Interaction | AR interactions | 3.27e-04 | 992 | 28 | 7 | int:AR | |
| Interaction | RACK1 interactions | 3.47e-04 | 704 | 28 | 6 | int:RACK1 | |
| Interaction | H2AC11 interactions | 3.63e-04 | 248 | 28 | 4 | int:H2AC11 | |
| Interaction | IFI16 interactions | 3.74e-04 | 714 | 28 | 6 | int:IFI16 | |
| Interaction | MYH15 interactions | 3.85e-04 | 21 | 28 | 2 | int:MYH15 | |
| Interaction | NUMA1 interactions | 4.22e-04 | 469 | 28 | 5 | int:NUMA1 | |
| Interaction | ATXN1 interactions | 4.32e-04 | 1039 | 28 | 7 | int:ATXN1 | |
| Interaction | LGR4 interactions | 4.47e-04 | 262 | 28 | 4 | int:LGR4 | |
| Interaction | SIRT7 interactions | 4.66e-04 | 744 | 28 | 6 | int:SIRT7 | |
| Interaction | USP14 interactions | 5.10e-04 | 489 | 28 | 5 | int:USP14 | |
| Interaction | HNRNPCL2 interactions | 5.29e-04 | 274 | 28 | 4 | int:HNRNPCL2 | |
| Interaction | RCOR1 interactions | 5.35e-04 | 494 | 28 | 5 | int:RCOR1 | |
| Interaction | H2AC12 interactions | 5.76e-04 | 118 | 28 | 3 | int:H2AC12 | |
| Interaction | TPR interactions | 5.82e-04 | 281 | 28 | 4 | int:TPR | |
| Interaction | CIT interactions | 5.95e-04 | 1450 | 28 | 8 | int:CIT | |
| Interaction | H2AC4 interactions | 5.96e-04 | 506 | 28 | 5 | int:H2AC4 | |
| Interaction | H1-1 interactions | 6.01e-04 | 507 | 28 | 5 | int:H1-1 | |
| Interaction | IKZF1 interactions | 6.38e-04 | 288 | 28 | 4 | int:IKZF1 | |
| Interaction | MAPRE1 interactions | 6.40e-04 | 514 | 28 | 5 | int:MAPRE1 | |
| Interaction | PRRC2C interactions | 6.55e-04 | 290 | 28 | 4 | int:PRRC2C | |
| Interaction | TLX3 interactions | 6.63e-04 | 291 | 28 | 4 | int:TLX3 | |
| Interaction | PAX7 interactions | 6.66e-04 | 124 | 28 | 3 | int:PAX7 | |
| Interaction | RABL6 interactions | 7.64e-04 | 130 | 28 | 3 | int:RABL6 | |
| Interaction | MED15 interactions | 7.81e-04 | 131 | 28 | 3 | int:MED15 | |
| Interaction | USP11 interactions | 7.93e-04 | 539 | 28 | 5 | int:USP11 | |
| Interaction | HDAC3 interactions | 8.71e-04 | 313 | 28 | 4 | int:HDAC3 | |
| Interaction | SFPQ interactions | 9.64e-04 | 563 | 28 | 5 | int:SFPQ | |
| Interaction | CHAF1A interactions | 9.67e-04 | 322 | 28 | 4 | int:CHAF1A | |
| Interaction | TLX2 interactions | 9.86e-04 | 142 | 28 | 3 | int:TLX2 | |
| Interaction | TCEANC2 interactions | 1.02e-03 | 34 | 28 | 2 | int:TCEANC2 | |
| Interaction | SALL3 interactions | 1.02e-03 | 34 | 28 | 2 | int:SALL3 | |
| Interaction | NOP56 interactions | 1.02e-03 | 570 | 28 | 5 | int:NOP56 | |
| Interaction | H2AC14 interactions | 1.03e-03 | 144 | 28 | 3 | int:H2AC14 | |
| Interaction | KLF8 interactions | 1.05e-03 | 329 | 28 | 4 | int:KLF8 | |
| Interaction | RPS6 interactions | 1.09e-03 | 874 | 28 | 6 | int:RPS6 | |
| Interaction | SRP72 interactions | 1.10e-03 | 333 | 28 | 4 | int:SRP72 | |
| Interaction | ZC3H18 interactions | 1.10e-03 | 877 | 28 | 6 | int:ZC3H18 | |
| Interaction | H2AC18 interactions | 1.11e-03 | 148 | 28 | 3 | int:H2AC18 | |
| Interaction | SMAD9 interactions | 1.22e-03 | 153 | 28 | 3 | int:SMAD9 | |
| Interaction | RHBDD1 interactions | 1.26e-03 | 346 | 28 | 4 | int:RHBDD1 | |
| Interaction | CPEB4 interactions | 1.29e-03 | 156 | 28 | 3 | int:CPEB4 | |
| Interaction | EWSR1 interactions | 1.31e-03 | 906 | 28 | 6 | int:EWSR1 | |
| Interaction | POLR1E interactions | 1.32e-03 | 350 | 28 | 4 | int:POLR1E | |
| Interaction | SOX6 interactions | 1.32e-03 | 157 | 28 | 3 | int:SOX6 | |
| Interaction | MAN2C1 interactions | 1.34e-03 | 39 | 28 | 2 | int:MAN2C1 | |
| Interaction | RPL5 interactions | 1.34e-03 | 606 | 28 | 5 | int:RPL5 | |
| Interaction | RNF181 interactions | 1.39e-03 | 160 | 28 | 3 | int:RNF181 | |
| Interaction | PYHIN1 interactions | 1.43e-03 | 358 | 28 | 4 | int:PYHIN1 | |
| Interaction | WDR77 interactions | 1.48e-03 | 361 | 28 | 4 | int:WDR77 | |
| Interaction | LOC102724594 interactions | 1.48e-03 | 41 | 28 | 2 | int:LOC102724594 | |
| Cytoband | 16q24.3 | 6.11e-04 | 52 | 32 | 2 | 16q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q24 | 4.08e-03 | 136 | 32 | 2 | chr16q24 | |
| GeneFamily | Canonical high mobility group | 4.02e-05 | 11 | 16 | 2 | 511 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 9.85e-04 | 53 | 16 | 2 | 532 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.15e-06 | 90 | 27 | 4 | M39250 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP | 4.84e-05 | 198 | 27 | 4 | M8041 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN | 5.03e-05 | 200 | 27 | 4 | M8039 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 5.64e-05 | 206 | 27 | 4 | M39254 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CLASSICAL_MONOCYTE_AGEING | 7.84e-05 | 441 | 27 | 5 | MM3765 | |
| Coexpression | FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN | 1.04e-04 | 89 | 27 | 3 | M7715 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 2.07e-05 | 983 | 27 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.24e-05 | 469 | 27 | 6 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | 7.96e-05 | 1187 | 27 | 8 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | |
| CoexpressionAtlas | e10.5_NeuroEpith_MedialEmin_top-relative-expression-ranked_500_4 | 1.20e-04 | 13 | 27 | 2 | Facebase_ST1_e10.5_NeuroEpith_MedialEmin_500_4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.42e-04 | 654 | 27 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_100 | 2.57e-04 | 98 | 27 | 3 | Facebase_RNAseq_e9.5_Mandibular Arch_100 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-08 | 184 | 27 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 1.23e-07 | 200 | 27 | 5 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.23e-07 | 200 | 27 | 5 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 1.23e-07 | 200 | 27 | 5 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 177 | 27 | 4 | 15d1de38e4f1a0d4a786d83ee92240f44bdff006 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 177 | 27 | 4 | b41e975e8368e2618b015be095efe8c0e001c78b | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 185 | 27 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-06 | 188 | 27 | 4 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 5.22e-06 | 192 | 27 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.33e-06 | 193 | 27 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.67e-06 | 196 | 27 | 4 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.78e-06 | 197 | 27 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.78e-06 | 197 | 27 | 4 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new|World / Primary Cells by Cluster | 5.90e-06 | 198 | 27 | 4 | 11d2d4d179bc31ef2897d7ceeaf9bed1b20cbdc0 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new-9|World / Primary Cells by Cluster | 5.90e-06 | 198 | 27 | 4 | c724ef958e14e17a7d8c02b9f842510c0780f635 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.02e-06 | 199 | 27 | 4 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.02e-06 | 199 | 27 | 4 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.02e-06 | 199 | 27 | 4 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.02e-06 | 199 | 27 | 4 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.02e-06 | 199 | 27 | 4 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.02e-06 | 199 | 27 | 4 | be425e9cb90a73289026b1b7cb581e1c02a8985e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.14e-06 | 200 | 27 | 4 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.14e-06 | 200 | 27 | 4 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.14e-06 | 200 | 27 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.14e-06 | 200 | 27 | 4 | c792d1dbbe27ebd60f4770834f30882c1a625be5 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.14e-06 | 200 | 27 | 4 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.26e-05 | 128 | 27 | 3 | 9ab55a0421cd970e0b8dabce67dd68e382a6bd41 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 162 | 27 | 3 | dddf7a3901ae59e3494d8a6740db0fa15cc96d47 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 162 | 27 | 3 | 2a4e09545e9874519f0f56e81065104987d81cd6 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 164 | 27 | 3 | 2a230ea066decb798a0e6f2b96c7608c8e608031 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 164 | 27 | 3 | d02d39edd0bfef5a53b814ec6d5f026d41253218 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 165 | 27 | 3 | 50a8513d8d2630861499393a7f102b35366bad37 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 167 | 27 | 3 | 1bd27ffe381d26731b6d4cc5f29b27f1bac4473b | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 168 | 27 | 3 | faaba5ac01c2ebe380f56559374a121979a85a13 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 170 | 27 | 3 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 171 | 27 | 3 | 58bdcbc65062ac09f1c014e08302f938a3e6b252 | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 1.50e-04 | 172 | 27 | 3 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.58e-04 | 175 | 27 | 3 | 2812ac2ef41d245db544697fb6da1883361c96e8 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-04 | 175 | 27 | 3 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 175 | 27 | 3 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | droplet-Marrow|droplet / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 177 | 27 | 3 | 0b8a1496c078874def0bfca0268136f1a84b82fd | |
| ToppCell | C_00|World / shred on cell type and cluster | 1.69e-04 | 179 | 27 | 3 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 1.74e-04 | 181 | 27 | 3 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-04 | 184 | 27 | 3 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.86e-04 | 185 | 27 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | (7)_MNP-(7)_DC_plasmacytoid|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.86e-04 | 185 | 27 | 3 | 9f67f652488e17075a372e2a2e1100f6d0af6d7d | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.86e-04 | 185 | 27 | 3 | 308a98f111895071d8772bc010554471cc12fab2 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | 3dcafbd02b65a2befbb6e6288cb2591e721cddb6 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | 4157cc14b06bb99ee67ac1526622cf546e727efc | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.89e-04 | 186 | 27 | 3 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-04 | 186 | 27 | 3 | 4fe8e0bf74c7dbf73634cafdacad89020d2634d0 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 186 | 27 | 3 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 186 | 27 | 3 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.89e-04 | 186 | 27 | 3 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 187 | 27 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 188 | 27 | 3 | 1526e271411e381eae7a342003002276f83f47a3 | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 1.95e-04 | 188 | 27 | 3 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-04 | 188 | 27 | 3 | 9858940c616e43441644c5a3bea8d832ee4daf79 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-04 | 188 | 27 | 3 | 33afe31b1093d317dc38c324197c6e91bf6c39d3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-04 | 188 | 27 | 3 | 459e3fd4335a6f25f982d011b38702f4fcfed1cd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-04 | 188 | 27 | 3 | 9fd262bbf6cdebfd945e39428a6059726fb55b3a | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 1.95e-04 | 188 | 27 | 3 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-04 | 190 | 27 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.01e-04 | 190 | 27 | 3 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.01e-04 | 190 | 27 | 3 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.01e-04 | 190 | 27 | 3 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-04 | 191 | 27 | 3 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 2.04e-04 | 191 | 27 | 3 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 2.04e-04 | 191 | 27 | 3 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 191 | 27 | 3 | ff2cc4c10aa584b3daeaaf23cd8ee09bdbdf684d | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.08e-04 | 192 | 27 | 3 | fcdb2e924800457d21e4aaeeedd81dbf80216eed | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.08e-04 | 192 | 27 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-04 | 192 | 27 | 3 | 86d561c30554ff04c21801d4aaf8e3c9efe49af4 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-Low_Quality|World / Primary Cells by Cluster | 2.08e-04 | 192 | 27 | 3 | 5fa5b2f250ec5ad5a232c022266f0cd01ff4a753 | |
| ToppCell | COVID-19_Severe-Myeloid_G-immature_Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 2.08e-04 | 192 | 27 | 3 | 303deb68da2e4a75e6ee5a79478182a8bc41c7c5 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-Low_Quality-16|World / Primary Cells by Cluster | 2.08e-04 | 192 | 27 | 3 | 0d6413df15dfecdffc777fb02df3aaf0c30540b1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 27 | 3 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.11e-04 | 193 | 27 | 3 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | control-pDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.11e-04 | 193 | 27 | 3 | 30a6559c9a9e8941861cb259b4836acccc427e68 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 193 | 27 | 3 | 444de545117dae8ab24a22880583ac2f0b2d6eac | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.11e-04 | 193 | 27 | 3 | ecbe1bd16df547427da5e69a3017300e766c2899 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 194 | 27 | 3 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-04 | 194 | 27 | 3 | 6cc689595a182fbf685fa2f3b9c300f7170fb81f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 194 | 27 | 3 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 194 | 27 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.14e-04 | 194 | 27 | 3 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 194 | 27 | 3 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Pro-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.14e-04 | 194 | 27 | 3 | 58d7c56d2b9c893b62da2334428d677e3451fe07 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 194 | 27 | 3 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 195 | 27 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 195 | 27 | 3 | db1660ce74819cd816bdcfcae5efb3aad82cce66 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 195 | 27 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| Computational | Neighborhood of ANP32B | 1.70e-03 | 37 | 18 | 2 | GNF2_ANP32B | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.74e-03 | 47 | 18 | 2 | GAVISH_3CA_METAPROGRAM_B_CELLS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.74e-03 | 47 | 18 | 2 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.97e-03 | 49 | 18 | 2 | GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.97e-03 | 49 | 18 | 2 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.97e-03 | 49 | 18 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.97e-03 | 49 | 18 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.09e-03 | 50 | 18 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.09e-03 | 50 | 18 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_3_CELL_CYLCE_HMG_RICH | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.09e-03 | 50 | 18 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.09e-03 | 50 | 18 | 2 | GAVISH_3CA_METAPROGRAM_B_CELLS_PROGENITOR | |
| Drug | etimizol | 1.35e-05 | 5 | 27 | 2 | CID000006168 | |
| Drug | cryptolepine | 6.06e-05 | 10 | 27 | 2 | CID000082143 | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 7.24e-05 | 191 | 27 | 4 | 4303_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.24e-05 | 191 | 27 | 4 | 6020_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 7.24e-05 | 191 | 27 | 4 | 3926_DN | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 7.85e-05 | 195 | 27 | 4 | 4019_DN | |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; PC3; HT_HG-U133A | 7.85e-05 | 195 | 27 | 4 | 4481_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 7.85e-05 | 195 | 27 | 4 | 6159_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 8.16e-05 | 197 | 27 | 4 | 3425_DN | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; PC3; HT_HG-U133A | 8.32e-05 | 198 | 27 | 4 | 1797_DN | |
| Drug | ST021200; Down 200; 10uM; MCF7; HT_HG-U133A | 8.32e-05 | 198 | 27 | 4 | 7554_DN | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.69e-05 | 7 | 27 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | eosinophil measurement | 1.31e-04 | 108 | 27 | 3 | EFO_0803540 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.82e-03 | 69 | 27 | 2 | DOID:1682 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 2.25e-03 | 616 | 27 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.25e-03 | 616 | 27 | 4 | C0376358 | |
| Disease | age at menopause | 2.59e-03 | 302 | 27 | 3 | EFO_0004704 | |
| Disease | albuminuria | 3.35e-03 | 94 | 27 | 2 | EFO_0004285 | |
| Disease | mean fractional anisotropy measurement | 3.42e-03 | 95 | 27 | 2 | EFO_0008399 | |
| Disease | Hypermetropia | 4.00e-03 | 103 | 27 | 2 | HP_0000540 | |
| Disease | fibrinogen measurement | 4.47e-03 | 109 | 27 | 2 | EFO_0004623 | |
| Disease | keratinocyte carcinoma | 5.21e-03 | 118 | 27 | 2 | EFO_0010176 | |
| Disease | cancer | 5.68e-03 | 400 | 27 | 3 | MONDO_0004992 | |
| Disease | cystatin C measurement | 5.76e-03 | 402 | 27 | 3 | EFO_0004617 | |
| Disease | melanoma | 5.92e-03 | 126 | 27 | 2 | EFO_0000756 | |
| Disease | skin pigmentation measurement | 6.96e-03 | 137 | 27 | 2 | EFO_0007009 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.50e-03 | 152 | 27 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | eosinophil count | 1.03e-02 | 1488 | 27 | 5 | EFO_0004842 | |
| Disease | mean arterial pressure | 1.04e-02 | 499 | 27 | 3 | EFO_0006340 | |
| Disease | autoimmune disease | 1.09e-02 | 173 | 27 | 2 | EFO_0005140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PKGKPCPKEIPKESK | 221 | Q9UKH3 | |
| KPPGLDPPFKDKKLK | 1641 | Q6UB99 | |
| PPKKGKEKPPKATKK | 116 | Q8IUX7 | |
| PPKATKKPKEKPPKA | 146 | Q8IUX7 | |
| KKPKEKPPKATKKPP | 151 | Q8IUX7 | |
| KPPKATKKPPSGKRP | 156 | Q8IUX7 | |
| QGLGKPKSKPKKPRP | 1356 | Q5T5Y3 | |
| KDPKEPKEPKEKKEP | 651 | Q9P2D1 | |
| PKEPKEKKEPKEPKT | 656 | Q9P2D1 | |
| EKKEPKEPKTPKAPK | 661 | Q9P2D1 | |
| PKAPKIPKEPKEKKA | 671 | Q9P2D1 | |
| PKGDKKGKKKDPNAP | 81 | P26583 | |
| KGKKKDPNAPKRPPS | 86 | P26583 | |
| KPEPKPKKAPAKKGE | 36 | P05204 | |
| PKKAPAKKGEKVPKG | 41 | P05204 | |
| PKGKPCPKEIPKESK | 111 | P61566 | |
| PKGKPCPKEIPKESK | 111 | P61567 | |
| PKPKRKREPKEPKEP | 116 | Q8TD26 | |
| PKKRRPPKAEKKKAP | 981 | Q6PD62 | |
| PKGKPCPKEIPKESK | 221 | P61565 | |
| PKGKPCPKEIPKESK | 111 | Q9HDB8 | |
| PPPTKKKGQKPGRKD | 201 | A6NNW6 | |
| PKPKAAKPKSGKPKV | 196 | P16402 | |
| GSPRVPDAKKPKPKK | 276 | Q14839 | |
| PDAKKPKPKKVAPLK | 281 | Q14839 | |
| AKPKGPPVQKKKPKV | 566 | Q8N807 | |
| PKEGKPKKKKTGAPP | 371 | Q8N1G1 | |
| LKPKKLPKPPAKLPK | 336 | Q9UGK3 | |
| PINKGPKPKREKKEP | 1296 | Q02880 | |
| DLPKKPPKPEFGKLK | 31 | Q96QH2 | |
| GKKREDPKPGPKKPK | 1626 | Q9Y520 | |
| DPKPGPKKPKEKVDA | 1631 | Q9Y520 | |
| PKPPKPDPLKITKGK | 976 | P48634 | |
| PTKVKAEPPPKKRKK | 1786 | Q9ULL5 | |
| KKKSGSKKKGEPGPP | 626 | Q9P2E9 | |
| KDGPISPKKKKPKER | 906 | Q8WWQ0 | |
| PRKKGPNSGKKEKPL | 306 | Q9UQR0 | |
| KGKGKPLQRKVKPPK | 1381 | Q92545 | |
| KKPGPKPGWKKKLRC | 411 | Q8N554 | |
| PKPKKAKDAGKGTPL | 121 | O15318 | |
| EQPLKTPGKKKKGKP | 116 | P12272 | |
| ELKKKKTPGPGKLPP | 746 | Q9BWU0 |